These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21048494)

  • 21. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
    Li Q; Fang H; Wang X; Hu L; Xu W
    Eur J Med Chem; 2009 Dec; 44(12):4819-25. PubMed ID: 19683842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
    Jin K; Zhang X; Ma C; Xu Y; Yuan Y; Xu W
    Bioorg Med Chem; 2013 May; 21(9):2663-70. PubMed ID: 23510562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
    Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.
    Li Q; Fang H; Wang X; Xu W
    Eur J Med Chem; 2010 Apr; 45(4):1618-26. PubMed ID: 20129718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synthesis and preliminary activity assay in vitro of peptide-like derivatives as APN inhibitors.
    Li SH; Li G; Huang HM; Xiong F; Liu CM; Tu GG
    Arch Pharm Res; 2008 Oct; 31(10):1231-9. PubMed ID: 18958412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.
    Su L; Jia Y; Wang X; Zhang L; Fang H; Xu W
    Bioorg Med Chem Lett; 2013 May; 23(9):2512-7. PubMed ID: 23528299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
    Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
    Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
    Jia M; Yang K; Fang H; Xu Y; Sun S; Su L; Xu W
    Bioorg Med Chem; 2011 Sep; 19(17):5190-8. PubMed ID: 21802307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary detection of the anti‑tumour activity of indoline‑2,3‑dione derivative DH‑12a targeting aminopeptidase N.
    Cui DX; Wang XJ; Zhang XR; Zhao TK; Guo XX; Liu SM; Wang B; Ma WQ; Gao ZQ
    Mol Med Rep; 2014 Nov; 10(5):2681-8. PubMed ID: 25216231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
    Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
    Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
    Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
    Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
    Li Q; Fang H; Xu W
    Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
    Saitoh Y; Koizumi K; Minami T; Sekine K; Sakurai H; Saiki I
    Biol Pharm Bull; 2006 Apr; 29(4):709-12. PubMed ID: 16595904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
    Li X; Wang J; Li J; Wu J; Li Y; Zhu H; Fan R; Xu W
    Bioorg Med Chem; 2009 Apr; 17(8):3053-60. PubMed ID: 19329328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
    Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
    Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel aminopeptidase N inhibitor developed by virtual screening approach.
    Feng J; Jin K; Zhu H; Zhang X; Zhang L; Liu J; Xu W
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5863-9. PubMed ID: 22901392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).
    Li X; Wang Y; Wu J; Li Y; Wang Q; Xu W
    Bioorg Med Chem; 2009 Apr; 17(8):3061-71. PubMed ID: 19339187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells].
    Qian XJ; Lin MF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1125-8. PubMed ID: 22040956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.